Neurocrine Bioscience buy Citigroup Inc.
Start price
12.02.26
/
50%
€103.35
Target price
12.02.27
€171.73
Performance (%)
8.32%
Price
09.03.26
€111.95
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ shows slight gains of 8.32%. This prediction currently runs until 12.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.104% |
| iShares Core DAX® | -3.520% |
| iShares Nasdaq 100 | 0.261% |
| iShares Nikkei 225® | -4.953% |
| iShares S&P 500 | -0.823% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $203.00 to $204.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
-4.93%
09.03.26
09.03.26
